Two-step screening for depressive symptoms in patients treated with kidney replacement therapies - cross-sectional analysis.
Sumaya DanoHaoyue Helena LanSara MacanovicSusan J BartlettDoris M HowellMadeline LiJanel HanmerJohn Devin PeipertMarta NovakIstvan MucsiPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
A 2-step screening using PHQ-2 ≥1 followed by PROMIS-D ≥53 has good sensitivity and specificity for identifying potentially significant depressive symptoms among patients on kidney replacement therapies. This approach has lower question burden. Screened-in patients will need further clinical assessment to establish diagnosis.